Kern Pharma, S.L.   Report issue

For profit Phase 3
Founded: Barcelona Spain (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2018
NCT03820453
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kern Pharma, S.L.

Active Ingredients

Drugs in Phase 3 Trials (1)

dexamethasone (1 trial)

Drugs in Other Trials (1)

tribulus terrestris (1 trial)

Indications

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2